.Attributes Medication, Posted online: 03 September 2024 doi:10.1038/ s41591-024-03223-zThis Standpoint asks for introduction of individuals with MASLD as well as size of liver end results in cardio-- renal-- metabolic trials, when data propose mechanistically probable perks and also scientific safety-- as well as describes factors for test concept as well as regulatory commendation.